Cargando…
Apoptosis of CD19(+) chimeric antigen receptor T cells after treatment with chemotherapeutic agents
The use of chemotherapeutic agents prior to treatment with infusion of cluster of differentiation (CD)19-chimeric antigen receptor (CAR)-T cells is important for the efficacy of clinical therapies against hematological malignancies. However, the effect of chemotherapeutic agents on CD19-CAR-T cells...
Autores principales: | Yi, Wenfang, Pei, Fuyu, Ding, Wen, Yang, Mo, Lin, Guang, Zhang, Cheng, Wu, Xuedong, He, Yuelin, Feng, Xiaoqin, Liu, Huanying, Peng, Zhiyong, Li, Chunfu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059667/ https://www.ncbi.nlm.nih.gov/pubmed/29749441 http://dx.doi.org/10.3892/mmr.2018.8943 |
Ejemplares similares
-
Chimeric antigen receptor T cells engineered to secrete CD40 agonist antibodies enhance antitumor efficacy
por: Zhang, Yajun, et al.
Publicado: (2021) -
Development of a monoclonal antibody for the detection of anti-canine CD20
chimeric antigen receptor expression on canine CD20 chimeric antigen receptor-transduced T
cells
por: SAKAI, Osamu, et al.
Publicado: (2021) -
Knockdown of the Inhibitor of Apoptosis BRUCE Sensitizes Resistant Breast Cancer Cells to Chemotherapeutic Agents
por: Garrison, Jason B, et al.
Publicado: (2015) -
The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28
por: Muller, Yannick D., et al.
Publicado: (2021) -
Evaluation of Chemotherapeutic Agents
por: Engstrom, W. W.
Publicado: (1949)